Drimva

GSK

Medical Director, Clinical Development, Hepatology

$223K–$371K

USA - Pennsylvania - Pennsylvania Central +2 · Hybrid (Remote & On-site) · Director · Full-time · Posted Oct 7, 2026

Location
USA - Pennsylvania - Pennsylvania Central
USA - Massachusetts - Waltham
UK - London
Experience
Pharmaceutical-industry clinical drug development experience required; no number of years stated.
Education
Medical degree; completed clinical residency leading to board qualification or certification.

About the job

Leads clinical and scientific development of hepatology assets, overseeing clinical plans and studies through registrational development and regulatory submissions.

What you'll do

  • Develop and execute clinical development plans, protocols, and evidence strategies with cross-functional teams.
  • Provide medical monitoring and safety oversight, and lead clinical study teams and regulatory interactions.
  • Contribute to global regulatory submissions and evaluate business development activities.

What they ask for

  • Medical degree and completed clinical residency leading to board qualification or certification.
  • Board qualification/registration in Internal Medicine or Primary Care / Family Medicine.
  • Pharmaceutical-industry experience in clinical drug development, including understanding trial execution from concept to publication and direct in-stream medical oversight.
  • Knowledge of ICH guidelines, FDA requirements, global regulatory expectations, clinical research methodology, and biostatistical principles.

Nice to have

  • Advanced clinical specialty training with board qualification/registration in Hepatology, or equivalent higher specialty training; hepatology clinical research experience.
  • Familiarity or experience in MASH or ALD drug development.

Pay

$222,750 to $371,250 USD annual base salary (for specified US locations)

Tools

digital tools, ICH guidelines, FDA requirements

Model-written summary · the original posting is authoritative

First seen Oct 28, 2026 · Last verified Nov 6, 2026 (UTC)